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for a role of sperm DNA testing in cases of implantation failure and 
recurrent miscarriage (RM). Therefore, the aim of this study was to 
add to this evidence base and examine the relationship between sperm 
DNA fragmentation in the male partners of women diagnosed with 
recurrent implantation failure (RIF) following IVF, RM and in men 
who had become recent fathers. We aimed to examine the effect of 
sperm preparation by density centrifugation and to assess sperm DNA 
fragmentation using two commercially available methods.
MATERIALS AND METHODS
Male partners were recruited from the Jessop Wing of Sheffield 
Teaching Hospitals NHS Foundation Trust (Sheffield, UK) between 
January 2010 and January 2011. For the purposes of this study, RIF 
was defined as the failure to achieve a clinical pregnancy following the 
transfer of four good quality embryos in a minimum of three fresh and 
frozen embryo cycles in women aged <40 years. A good quality embryo 
was defined as having the correct number of cells corresponding to 
the day of its development, blastomeres of equal size and regular in 
distribution, even distribution of the cytoplasm without granularity 
and less than 10% fragmentation.16 RM was defined as three or more 
consecutive and unexplained pregnancy losses occurring before 
20 weeks postmenstruation.17–19
All couples (both RIF and RM groups) had normal karyotypes and 
there was no evidence of risk factors for RIF and RM in the female 
partners: there were no endocrine disorders, negative testing for 
antiphospholipid antibodies and lupus antibodies, normal coagulation 
INTRODUCTION
Male-factor continues to account for approximately 20% of cases of 
infertility and in an additional 30%–40% of cases causative factors are 
identified in both men and women.1 Assessment of male infertility 
traditionally has depended on the analysis of a semen sample 
according to World Health Organization (WHO) guidelines.2,3 This 
analysis is based on a visual estimation of sperm number, motility, 
and morphology as measured by light microscopy and is difficult to 
perform reliably.4 Sperm DNA integrity testing has therefore been 
proposed to be a test with promising potential to compliment the 
standard semen analysis.5
Many studies have reported an adverse effect of sperm DNA 
damage on fertility. Sperm DNA fragmentation is associated with 
failure to conceive,6 longer times to pregnancy,7 poor outcome 
following stimulated intrauterine insemination,8,9 impaired embryo 
development,10 higher miscarriage rates11 and increased risk 
of pregnancy loss after both in  vitro fertilization  (IVF) and 
intracytoplasmic sperm injection.12 Sperm DNA damage may, 
therefore, have far reaching consequences for reproductive outcome.
In spite of the above data, separate reports from the American 
Society for Reproductive Medicine,13 the European Society for Human 
Reproduction and Embryology,14 and the British Fertility Society15 
have all concluded that at the present time there is insufficient 
evidence for sperm DNA testing to be introduced as part of clinical 
practice with the need for further research being identified. However, 
all three reports conclude that the strongest evidence is currently 
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Evidence is increasing that the integrity of sperm DNA may also be related to implantation failure and recurrent miscarriage (RM). 
To investigate this, the sperm DNA fragmentation in partners of 35 women with recurrent implantation failure (RIF) following 
in vitro fertilization, 16 women diagnosed with RM and seven recent fathers (control) were examined. Sperm were examined 
pre- and post-density centrifugation by the sperm chromatin dispersion (SCD) test and the terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL) assay. There were no significant differences in the age of either partner or sperm concentration, 
motility or morphology between three groups. Moreover, there were no obvious differences in sperm DNA fragmentation measured 
by either test. However, whilst on average sperm DNA fragmentation in all groups was statistically lower in prepared sperm when 
measured by the SCD test, this was not seen with the results from the TUNEL assay. These results do not support the hypothesis 
that sperm DNA fragmentation is an important cause of RIF or RM, or that sperm DNA integrity testing has value in such patients. 
It also highlights significant differences between test methodologies and sperm preparation methods in interpreting the data from 
sperm DNA fragmentation tests.
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and absence of uterine structural abnormalities. Male partners had 
no history of orchitis, testicular trauma, varicocele, testicular torsion, 
toxic exposure, chronic illness and prior gonadotoxic therapy. All 
participants  (including the control group) were nonsmokers. The 
control group consisted of men who were of proven fertility without 
the use of assisted conception and with no history of fertility problems, 
and these were recruited from posters displayed around the hospital. 
The study was approved by the South Sheffield Research Ethics 
Committee  (08/H1310/90) and approved by the Sheffield Teaching 
Hospitals Clinical Governance procedures (STH 15116).
Information leaflets explaining the study were provided to every 
participant and written informed consent obtained. Semen samples 
(one per subject) were obtained by masturbation following 3–4 days 
sexual abstinence. Samples were collected in sterile plastic containers 
(Sarstedt, Leicester, UK) and allowed to liquefy at 37°C for 30 min 
before the semen analysis according to WHO methods.2 Following 
semen analysis, sperm were isolated from seminal plasma using an 
80/40% density centrifugation gradient (Cook UK Ltd., Hitchin, UK) 
and centrifuged at 500 × g for 20 min before being washed in 3 ml 
Fertilization Medium (Cook UK Ltd., Hitchin, UK) at 500 × g for 5 min, 
and then finally resuspended in a further 0.3 ml of Fertilization Medium.
Two testing methods were used to measure sperm DNA integrity on 
both the neat (unprepared) sperm, as well as sperm recovered following 
density centrifugation (prepared) as described below.
The terminal deoxynucleotidyl transferase dUTP nick end 
labeling  (TUNEL) assay was performed using the Fluorescein 
FragELTM DNA Fragmentation Detection Kit  (Merck Chemicals 
Ltd., Nottingham, UK). Briefly, prepared and unprepared samples of 
semen (see above) were centrifuged at 1000 × g for 10 min and the sperm 
pellet resuspended in 500 µl tris buffered saline (TBS) (50 mmol l−1 
Tris pH  7.9  [VWR, Lutterworth, UK]; 150 mmol l-1 NaCl [Sigma, 
Poole, UK]) before being centrifuged again at 1000 × g for 5 min and 
the supernatant again removed carefully without disturbing the pellet. 
The pellet was then resuspended in a volume of TBS to achieve a final 
concentration of sperm of approximately 5 × 106 sperm ml−1. Aliquots 
of 100 µl of this suspension from both prepared and unprepared sperm 
were pipetted onto poly-lysine coated slides (VWR, Lutterworth, UK) 
and left to dry overnight before being fixed by being covered with 
approximately 1 ml of 100% (v/v) methanol (Fisher, Loughborough, 
UK) for 1 min and allowed to dry. Prior to staining, the outline of 
the fixed smear on each slide was encircled using a hydrophobic slide 
marker and then the cells contained within were covered with 50–100 µl 
of 20 µg ml−1 proteinase K and incubated at room temperature for 
5 min. Each slide was then dipped into a beaker of 1 × TBS 2–3 times 
and excess liquid gently tapped off and then the smear covered with 
100 µl of 1 × TdT equilibration buffer supplied by the kit and incubated 
at room temperature for 30 min. A 60 µl aliquot of TdT labeling reaction 
mixture was then applied, and the slide incubated in a humidified 
chamber at 37°C for 1.5 h. After washing each slide twice in 1 × TBS 
for 1 min at room temperature, a glass coverslip was mounted using 
Vectashield (Vector Laboratories, Peterborough, UK) with propidium 
iodide. Labeled nuclei were observed on an Olympus BH2 Fluorescent 
Microscope using a standard DAPI (4,6,-diamidino-2-phenyllndole) 
filter, 330–380 nm using a ×100 oil immersion lens. A total of 400 sperm 
were evaluated per slide and the number with a bright green signal 
(indicating DNA fragmentation) was recorded as a proportion of the 
number of sperm colored red (i.e., with intact DNA). In each case, 
control slides provided by the test kit (containing a mixture of normal 
and apoptotic cells) were also stained as a check to make sure the 
staining had worked correctly.
The sperm chromatin dispersion  (SCD) test20 was performed 
using a Halosperm Kit  (Microm, Bicester, UK) following the 
manufacturer’s instructions. Briefly, this involved adjusting the 
concentration of prepared and unprepared sperm  (see above) with 
Fertilisation Medium (Cook UK Ltd., Hitchin, UK) to a concentration 
of 5–10 million ml−1 and then adding 12.5 µl of each sample to 
50 µl of melted agarose in a clean Eppendorf tube (Starlabs, Milton 
Keynes, UK). A 10 µl aliquot of the mixture was then pipetted onto 
an agarose treated side of the glass slide and covered with a coverslip 
before being placed in the refrigerator a 2°C for 5 min. The coverslip was 
removed, and the slide immersed for 7 min in a tray containing 10 ml 
of distilled water to which 80 µl of the denaturant solution supplied 
by the kit had been added. The slides were then transferred to the lysis 
solution for 25 min before being washed in distilled water for 5 min 
and then passed through an alcohol series of 70% ethanol (2 min), 90% 
ethanol (2 min) and 100% ethanol (2 min). Slides were then allowed to 
dry at room temperature and then incubated with the eosin solution, 
for 6 min followed by a further 6 min in Azur B (blue). The slides were 
then rinsed briefly in distilled water, air-dried and a coverslip mounted 
using DPX (Sigma, Poole, Dorset, UK). Two hundred spermatozoa 
were examined per unprepared and prepared sample using a Leica 
DM LB Phase Contrast Microscope (Leica, Milton Keynes, UK) at a 
magnification of ×400. Sperm not demonstrating a halo represented 
those with fragmented DNA and were expressed as a proportion of 
the total number of sperm observed.
Statistical analysis was performed using the Statistical Package 
for the Social Sciences (SPSS Inc. Chicago, IL, USA). The Chi-square 
test, Fisher’s exact test and ANOVA were used for categorical 
variables, and an independent sample t-test was used for continuous 
variables that were normally distributed. P < 0.05 was considered 
as significant.
RESULTS
The partners of 35 women with RIF, 16 women with RM, and 7 controls 
were recruited to the study and provided semen samples for analysis. 
There were no significant differences between the three groups in terms 
of the age of either partner or in sperm concentration, motility and 
sperm morphology of the ejaculate provided for the study (Table 1).
Figure 1 shows the DNA fragmentation measured by the SCD test 
and TUNEL assay in each of the three groups (RIF, RM and control) 
of sperm in semen and sperm recovered following density gradient 
centrifugation  (DCG). Briefly, across semen samples, although the 
mean values obtained for percentage of sperm with fragmented DNA 
were numerically higher with the SCD test compared with the results 
of the TUNEL assay, there was only a statistical difference (P < 0.05) 
between the results obtained on sperm from the recent fathers 
(cf. Figure 1e and 1f). About sperm obtained following DCG, there 
were no statistical differences in the percentage of sperm with DNA 
damage between the three patient groups and the two test methods.
Table 1: Age and semen analysis data of the ejaculate provided by the 
male partners of women with RIF, RM and from recent fathers (control)
RIF (n=35) RM (n=16) Control (n=7) Significance
Female age (year) 34.7±1.4 36.4±0.9 35.5±1.2 0.930
Male age (year) 36.7±0.7 35.3±0.9 36.8±1.2 0.434
Sperm concentration 
(×106 ml−1)
56.9±7.6 62.5±10.9 58.2±23.2 0.923
Sperm motility (%) 61.1±2.9 65.1±5.0 70.7±7.8 0.411
Sperm morphology (%) 5.4±0.8 5.6±1.0 8.3±3.7 0.428
Data shown is mean±s.e.m. RIF: recurrent implantation failure; RM: recurrent miscarriage
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In comparing the semen and DCG results from each test, the 
mean  ±  s.e.m. for the SCD test were significantly different for the 
RIF (20.1 ± 2.9 vs 10.6 ± 2.9; P = 0.000), RM 15.1 ± 3.6 vs 2.8 ± 0.8; 
P = 0.005) and control groups (16.4 ± 3.7 vs 5.4 ± 1.3; P = 0.03) but 
no such statistical differences were seen between the results of the 
TUNEL assay. Interestingly, the values for sperm morphology were 
also not significantly different between sperm observed in semen and 
those assessed following DCG (data not shown).
DISCUSSION
This study investigated the relationship between sperm DNA 
fragmentation in the male partners of women diagnosed with RIF 
following IVF, RM following unassisted conception as well as sperm 
from men who had become recent fathers as a control group. This study 
used two commercially available tests and examined both ejaculated 
sperm as well as sperm recovered following density centrifugation. 
In summary, although some significant quantitative differences were 
seen in the results obtained with the two tests and sperm preparation 
methods across the three groups, there was no convincing evidence 
that the results could be used to discriminate between the three groups.
Recurrent implantation failure and RM are two types of 
reproductive failure with different incidences and presentations. 
A history of three or more consecutive miscarriages (RM) is somewhat 
rare occurring in approximately 0.5%–3% of women21 whereas 
following IVF as many as 48% of patients do not achieve a live birth 
after 3 cycles of treatment and therefore classified as RIF.22 RIF causes 
considerable distress to women and their partners and poses significant 
problems for clinicians. Women with RM have a different experience 
to women with RIF, achieving spontaneous conceptions but repeated 
pregnancy loss. They experience both joy and excitement at the 
prospect of a new addition to their family, only to be disappointed 
at a later time when a spontaneous pregnancy loss is confirmed on 
ultrasound or the woman experiences vaginal bleeding.
Previous studies to examine sperm DNA fragmentation in RM 
patients have shown mixed results. For example, the use of acridine 
orange staining on the sperm from 74 male partners of women with 
a history of RM found a statistical difference compared to the sperm 
from 65 recent fathers.23 Similarly, the use of the TUNEL assay on 
sperm from 24 couples with unexplained recurrent pregnancy loss 
was significantly different from the sperm obtained from donors of 
known fertility and unscreened men from the general population.24 
In contrast, sperm chromatin integrity was examined on isolated 
motile sperm from 23 couples with recurrent pregnancy loss and 
11 recent fathers to find that the results from the Sperm Chromatin 
Structure Assay  (SCSA) had no weight in the analysis.25 Similarly, 
Y chromosome microdeletions, sperm DNA fragmentation and sperm 
oxidative stress were examined as causes of recurrent spontaneous 
abortion of unknown etiology and it was concluded that sperm DNA 
fragmentation lacked an adequate predictive power to be employed 
as a discriminative test of recurrent spontaneous abortion.26 However, 
across 16 studies involving 2969 patients, a meta-analysis11 showed that 
there was a significant increase in miscarriage in patients with high 
DNA damage (risk ratio = 2.16 [1.54, 3.03], P < 0.00001) compared 
with those with low DNA damage. Moreover, there was significant 
heterogeneity in the type of test used to generate the DNA damage 
results (i.e., acridine orange-based assays, the TUNEL assay and the 
CometAssay). This may be related to the type of DNA damage being 
detected by these tests, and it is noteworthy that a small study in 
20 couples using the alkaline and neutral CometAssay, SCD test and 
pulsed-field gel electrophoresis suggested that it was double stranded 
DNA damage that was related to the risk of undergoing a male-factor 
associated miscarriage.27
In contrast to studies looking at RM, there are relatively few 
studies that have considered sperm DNA damage in patients with RIF 
following IVF. For example, 154 embryos from 38 patients undergoing 
preimplantation diagnoses were examined and it was found that 
although the sperm samples showed an increased DNA fragmentation 
after sperm preparation, there was no correlation between DNA 
fragmentation and the aneuploidy rate in embryos or in fresh or 
processed sperm samples.28
To conduct this study, two commercially available tests were chosen 
to measure sperm DNA fragmentation: (i) the SCD test; and (ii) the 
TUNEL assay. Both are available in kit form and can be used in a busy 
clinic with only basic laboratory equipment. In spite of their simplicity, 
these tests measure DNA fragmentation in different ways with the 
TUNEL assay detecting both single-  and double-stranded DNA 
breaks by labeling the free 3’-OH terminus with modified nucleotides 
leading to a fluorescent signal.29 In contrast, the SCD test is based on 
the principle that only sperm with unfragmented DNA will produce 
a characteristic halo of dispersed DNA loops following denaturation 
by acid and the removal of nuclear proteins.20
In addition to measuring DNA fragmentation of sperm in the 
unprocessed ejaculate, the study also examined sperm recovered 
Figure 1: Percentage of sperm with DNA fragmentation in male partners of 
women with recurrent implantation failure (a and b), recurrent miscarriage 
(c and d), and in a group of recent fathers (control) (e and f) as measured 
by sperm chromatin disruption test (left hand graphs) and terminal 
deoxynucleotidyl transferase dUTP nick end labelling (right hand graphs). 
All measurements were made on sperm in semen and immediately following 
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following density centrifugation. These represent different populations 
of sperm akin to those that might be deposited in the vagina during 
coitus (or ejaculated sperm in the case of RM patients) and those that 
might be used to inseminate oocytes during IVF (and therefore be 
the important population to consider in cases of the RIF patients 
recruited). Previous authors have noted that there can be increased 
levels of DNA fragmentation associated with sperm recovered from 
DCG30–32 presumably associated with increased incubation time 
and the centrifugation force involved. However, in this study sperm 
recovered from density centrifugation on average had lower levels of 
DNA damage, although this was only statistically significant when the 
SCD test (and not the TUNEL assay) was used. This may reflect known 
differences with the TUNEL assay33 although may also reflect genuine 
biological differences in sperm populations that we cannot explain. In 
this context it is noteworthy that in 8 out of the 35 samples from RIF 
patients examined using the TUNEL assay  (Figure  1b) showed an 
increase sperm DNA fragmentation following DCG, compared to only 
1 out of 35 when the same samples were examined using the SCD test. 
Interestingly, in the RM and control groups the level of sperm DNA 
fragmentation in each sample measured by both tests declined in line 
with the mean results.
This study has some limitations perhaps most notably that for 
all groups  (RIF, RM and control) the sperm examined for DNA 
fragmentation were not from the ejaculates that led to conception, 
but from specimens that were produced at a later time for research 
purposes. We are confident that for RIF and RM patients this was 
always within 6  weeks at the patient’s next follow-up appointment 
and for men in the control group they were all recruited within the 
first trimester of pregnancy. Therefore, there are possible differences 
between groups that are important to acknowledge, as it is known that 
sperm DNA fragmentation is influenced by environmental and lifestyle 
factors34 and hence it remains possible that the extent of sperm DNA 
fragmentation in each man may have changed over time.
In addition, it was also only possible to use two tests of sperm DNA 
fragmentation and it is plausible that if the SCSA35 or the CometAssay36 
had been used, different results may have been obtained. Finally, the 
groups in this study were unequal and it was easier to recruit to the 
study the male partners of women who had RIF following IVF than 
it was the male partners of women who had suffered RM or recent 
fathers (control). The difficulty in recruiting men to studies concerned 
with fertility is well-described37 and needs to be acknowledged.
CONCLUSION
Based on the results presented here, it is not possible to support the 
hypothesis that sperm DNA fragmentation is an important cause of 
RM or RIF, nor that these tests of DNA fragmentation have predictive 
value in the prospective identification of women at risk of RM and 
RIF. However, the paper does provide further insight into the use of 
commercially available test kits for the measurement of sperm DNA 
fragmentation and the impact of sperm preparation methods such as 
density centrifugation.
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